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Abstract Copy number variation (CNV) in terms of
aneuploidies of both entire chromosomes and chromo-
somal segments is an important evolutionary driving
force, but it is inevitably accompanied by potentially
problematic variations in gene doses and genomic
instability. Thus, a delicate balance must be maintained
between mechanisms that compensate for variations in
gene doses (and thus allow such genomic variability) and
selection against destabilizing CNVs. In Drosophila,
three known compensatory mechanisms have evolved: a
general segmental aneuploidy-buffering system and two
chromosome-specific systems. The two chromosome-
specific systems are the male-specific lethal complex,
which is important for dosage compensation of the male X
chromosome, and Painting of fourth, which stimulates
expression of the fourth chromosome. In this review, we
discuss the origin and function of buffering and compen-
sation using Drosophila as a model.
Introduction
Generally, we consider humans and most animals to be
diploid, i.e., that two copies of nearly all nuclear genes and
chromosomal regions are present in all of their cells except
gametes. However, many plants and some animals are
polyploids, i.e., their cells contain one or more additional
copies of their entire genome. In humans, polyploid
embryos are sometimes formed by fertilization of oocytes
by more than one sperm or by faulty meiosis that results in
diploid gametes. These embryos usually die early, few
surviving until birth. Mature humans are never true
polyploids, but some of our tissues contain extra sets of
chromosomes. For example, the liver contains cells with up
to eight copies of all chromosomes (octoploidy). Variations
in the number of individual chromosomes (aneuploidy) are
more common than polyploidy in humans. Aneuploidies
are formed when chromosomes fail to segregate properly
during cell division (non-disjunction) and severe syndromes
arise when embryos are formed by aneuploid gametes.
Classic examples include Down's syndrome (caused by
triploidy of chromosome 21) as well as Turner's and
Klinefelter's syndromes (caused by aberrant numbers of X
chromosomes).
Following the recent revolution in whole genome
analysis techniques (e.g., microarrays and next genera-
tion sequencing), it has become clear that the copy
number of parts of chromosomes (Fig. 1) varies quite
extensively in human populations. In fact, if two individ-
uals are randomly picked from any natural population of
any species, there are likely to be dozens to hundreds of
copy number differences of their functional genes
(Schrider and Hahn 2010). Due to resolution limitations
of micro-array techniques, most studies have focused on
copy number variations (insertions/deletions) (CNVs) of
sequences ranging in size from ca. 1-k bases to several
mega bases. Coming population studies using sequencing
approaches will likely give a more complete understand-
ing of the extent of CNV in nature. However, based on
currently available evidence, it has been estimated that
about 13% of the human genome varies in copy number
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CNVs compared to SNPs (Stankiewicz and Lupski 2010).
It is clear that eukaryotic (and hence human) evolution has
been significantly shaped by CNVs. Therefore, CNVs
presumably do not necessarily have strong negative effects
on fitness. On the other hand, changes in numbers of gene
copies should generally be proportionally reflected in the
RNA levels. Thus, since higher organisms invest substantial
effort in maintaining appropriate expression levels for
balancing their complex physiological processes, changes in
copy number should theoretically be selected against. How-
ever, considering the importance of CNVs for evolution, we
also expect systems to have evolved that compensate for the
differencesingenedosesaccompanyingCNVs,andthatthese
conflicting requirements must be balanced.
Relationship between gene dose and transcription
responses
Until recently, we have had very little insight into the ways
that changes in numbers of chromosomes or parts of
chromosomes affect gene expression levels, in large part
because obtaining accurate measurements of genome-wide
expressional effects of CNVs is difficult. Thus, to elucidate
the effects of CNVs on gene expression, we need good
model systems. Fortunately, we now have techniques to
accurately measure global gene expression, and Drosophila
melanogaster represents a good and well-annotated model
system. Therefore, this review mainly focuses on recent
discoveries in Drosophila.
In D. melanogaster, a vast number of well-defined
deletions and duplications are available, and new ones
can easily be induced in any region of interest. These
chromosomal rearrangements can then be observed in
isolation or in combination with other rearrangements.
Bridges (1935) divided the D. melanogaster genome into
102 regions based on chromosomal banding patterns.
These regions have a median size of just over one mega
basepairs, and deletions spanning more than one such
region (about 1% of the genome) are usually lethal
(Lindsley et al. 1972), although when one copy of a
single gene is deleted or mutated, one rarely detects any
phenotypic effect. The reduction in viability or lethality
seen when many genes are present in only one copy may
be due to several factors. It could be due to the additive
effects of many slightly dosage-sensitive genes, the
breakdown of gene networks, or the uncovering of
recessive lethal alleles. In general, organisms seem to
tolerate extra copies of genomic regions much better than
a reduced number of copies (Lindsley et al. 1972).
Few attempts have been made to study the effects of
copy number variation on transcription levels in any
detail. However, some attempts have been made in
human aneuploidies (see for instance FitzPatrick et al.
(2002)). Such studies generally examine changes in the
expression of all genes with altered copy levels. However,
genes that are inactive under the test conditions and genes
with expression levels below the detection level will
appear to be unaffected by the copy number, complicating
attempts to assess the variations and their biological
significance. For instance, Gupta et al. (2006) showed
that a threefold change in copy number of a genomic
region in flies only resulted in a ~1.4-fold change in
average mRNA levels, but non-expressed genes were
included in this study, thus the results are difficult to
interpret. Later, Stenberg et al. (2009) showed that both
single-copy and three-copy genomic regions are expressed
more closely to wild-type levels than would be expected if
mRNA levels correlated perfectly to gene dose. The effect
was detectable even after taking inactive genes into
account, and haploid regions seem to be more strongly
buffered (expressed at 64% of wild type, diploid levels)
than regions in three copies (expressed at 146% of wild-
type levels). Interestingly, genes that are not ubiquitously








Fig. 1 Schematic illustration of CNV (copy number variation). a
Chromosomal CNV; chromosomes 1, 2,a n d3 are in diploid, trisomic,
and monosomic states, respectively. b Segmental CNV; chromosome 1
represents the wild-type condition, while chromosomes 2 and 3 illustrate
segmental aneuploidies. Chromosome 2 shows a deletion leading to a
segmental haploid condition, and chromosome 3 shows a duplication
leading to a segmental triploid condition. Note that the duplication
(shaded box) may be located on any chromosome
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expressed genes are more strongly buffered (~138% of
wild-type levels) when in three copies. Recently, similar
effects were observed by McAnally and Yampolsky
(2010). In addition, RNA-Seq and DNA-seq analysis has
shown that >43 Mbp of the genome of Drosophila S2 cells
line is aneuploid (Zhang et al. 2010). The cited authors
found that the copy number varies from one to five, and
they detected a general buffering of transcript levels.
These findings imply that aneuploid regions are buffered
at the RNA level. The observations by Stenberg et al.
(2009) implied the involvement of a general buffering
system acting on the aneuploidy region rather than
feedback regulation of individual genes at a gene-by-
gene level. Two possible explanations of these findings
are that activators or repressors recruited by feedback-
regulated genes could locally spread to neighboring genes,
thus causing a general buffering effect for aneuploid
regions, or currently unknown buffering mechanisms
may recognize and target aneuploid regions of the
genome.
The findings summarized above show that buffering of
aneuploid regions does not restore wild-type expression
levels completely. This could be due to the evolutionarily
conflicting nature of such systems. On one hand, chromo-
somal rearrangement is clearly an important driving force
of evolution, hence cells and organisms need to be able to
cope with them. On the other hand, a perfect buffering
system would risk destabilizing the genomic integrity since
the selection against aneuploidy would be lowered. Evi-
dently, the organization of genes along chromosomes is far
from random. Expressional clustering is common, for a
review, see Hurst et al. (2004), and there is also evidence of
functional clustering, see for instance Petkov et al. (2005).
Many mechanisms, acting at several levels, could be
involved in the buffering of aneuploid regions. Clearly,
buffering at the RNA level occurs, and a yeast selection
study recently showed that mutations inducing ubiquitin-
proteasomal degradation reduces the deleterious effects of
extra copies of entire chromosomes, suggesting that
buffering also acts at the protein turnover level (Torres et
al. 2010). Thus, a number of mechanisms working at
different levels can probably reduce the deleterious effects
of chromosomal rearrangements, and we are just beginning
to elucidate these mechanisms and their effects.
There are also two well-studied examples of buffering of
entire chromosomes. These are the dosage compensation of
the single male X chromosome in Drosophila and the
compensation of the heterochromatic fourth chromosome
(Fig. 2). Both are reviewed below, and we use here the term
compensation (rather than buffering) for these systems as
their evolution has solved specific dosage and expression
problems associated with distinct parts of the genome. In
contrast, the buffering system reviewed above is general.
However, many mechanisms might still be shared between
buffering and the two compensation examples.
Dosage compensation
In many species, sex determination is associated with
heteromorphic sex chromosomes, for example, the X and
Y chromosome pair in mammals, which has arisen from
autosomes. A Y chromosome can evolve when a gene on a
chromosome acquires the ability to determine the male sex.
This newly formed chromosome, the proto-Y, will only
passage through a single sex. Mutations that favor the male
sex are predicted to be accumulated on the proto-Y
chromosome, which will eventually suppress recombina-
tion, leading to the further accumulation of mutations and
mobile elements and eventually loss of genes and degen-
eration (Charlesworth 1996). The formation of heteromor-
Fig. 2 Immunostaining of poly-
tene chromosomes in Drosophila
melanogaster reveals compo-
nents of the two chromosome-
wide targeting and gene regula-
tory systems. The MSL-C tar-
geting the entire male X
chromosome is visualized by an
antibody recognizing MSL3
(green). The fourth chromosome
is targeted by POF (red)a n d
DNA is counterstained with
DAPI (blue)
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times in evolution, and their formation is accompanied by
an expression problem that must be solved by the co-
evolution of mechanisms that compensate this unbalance.
Since most genes on the X chromosome should be
expressed at the same amounts in males and females, the
gradual degeneration of the Y chromosome will select for
systems that compensate for the different doses of the genes
located on the X chromosome, as reviewed by Larsson and
Meller (2006), Mank (2009) and Vicoso and Bachtrog
(2009). This dosage-compensating system should restore
the balance between expression from the X chromosome
and the autosomes and also compensate for the imbalance
of X chromosome between males and females. Here, we
focus on Drosophila, in which chromosome evolution and
dosage compensation have been studied in detail.
The gradual degeneration of the Y chromosome is
compatible with an emerging need for dosage compensation
at a gene-by-gene level. However, it is not known whether the
degeneration of the Y chromosome resulted from a gradual
accumulation of slightly deleterious mutations scattered along
the chromosome or largely from strongly deleterious muta-
tions of individual genes. These possibilities have different
implications for the selective forces promoting dosage
compensation, since the former should theoretically favor
compensation mechanisms acting on blocks of genes, while
the latter should favor mechanisms acting on individual genes
(Vicoso and Bachtrog 2009). The required up-regulation of
genes in the heterogametic sex together with tolerance of
overexpression in the female sex, will determine the levels of
expression regulation that are most effective for evolutionary
change. Dosage compensation mechanisms can potentially
evolve at diverse levels of expression regulation, but in
principle, we would expect them to be as sex-specific as
possible and only act on active genes. An ideal compensa-
tory system should not cause general de-repression of all X-
linked genes. We delineate some of the levels that could
potentially be targets for evolution of dosage-compensation
mechanisms and discuss the support for them below.
A progressive degeneration of the proto-Y chromosome
will inevitably lead to evolutionary pressure at all levels of
expression to compensate for the losses of functional gene
copies, which should intuitively develop initially (as the
aneuploidy emerges) largely on a gene-by-gene basis. An
early view in line with this hypothesis was that cis-acting
elements close to individual genes are important for this
response (Baker et al. 1994). For individual genes, e.g., the
white gene, such cis-acting elements have indeed been
reported (Qian and Pirrotta 1995). Following the identifi-
cation of the specific genes on the X chromosome that are
dosage compensated in genome-wide investigations in
combination with extensive sequence analysis, no unam-
biguous evidence for cis-acting elements for individual
genes on this chromosome has been reported (Alekseyenko
et al. 2006; Dahlsveen et al. 2006; Gilfillan et al. 2006;
Alekseyenko et al. 2008). However, although no cis-acting
elements have been identified as a general feature of the
dosage-compensated genes, significant overrepresentation
of a sequence motif targeted by the DREF (DNA
replication element factor) protein has been reported in
the 5′ region of X chromosomal genes targeted by the male-
specific lethal complex (MSL-C) (Legube et al. 2006). The
MSL-C is a ribonucleoprotein complex that targets X
chromosome genes in males, and its targeting correlates to
and can explain most of the observed dosage-compensating
effects on the male X chromosome, as reviewed by Straub
and Becker (2007), Gelbart and Kuroda (2009), and
Hallacli and Akhtar (2009). The complex consists of five
proteins, each required for male viability (MSL1, MSL2,
MSL3, MLE, and MOF), together with two redundant non-
coding RNAs: roX1 and roX2. The MSL-C only forms in
males, due to the sex-restricted expression of MSL2, where
it binds within the gene body of active X chromosome
genes and the acetyltransferase MOF acetylates H4K16.
This acetylation becomes strongly enriched in X chromo-
somal genes of males, and the prevailing models assume
that enrichment of H4K16ac leads to decompaction of the
chromatin fiber, which then increases gene transcription.
Recent data suggest that the MSL-C also has intrinsic
properties that constrain the activation potential of MOF,
resulting in the required twofold activation of target genes
(Prestel et al. 2010b). It should be noted that in msl2
mutants or in RNAi-mediated knock-downs of msl2 or mof,
the male X chromosome expression decrease to ~75% of
wild-type expression, suggesting that MSL-C does not
mediate the entire twofold activation (Hamada et al. 2005;
Deng et al. 2009; Zhang et al. 2010).
The prevailing model of the targeting is that the MSL-C is
recruited in a sequence-dependent manner to 150–300 high-
affinityMSLrecognitionelements(MRE)(Alekseyenkoetal.
2008). This is followed by a spreading to neighboring genes,
which depends on the local MSL complex concentration
(Dahlsveen et al. 2006), X chromosome location (Gorchakov
et al. 2009), and active transcription (Sass et al. 2003;
Larschan et al. 2007). The mechanisms of the MSL-C have
been reviewed in detail (Gelbart and Kuroda 2009;H a l l a c l i
and Akhtar 2009; Prestel et al. 2010a) and will not be further
discussed here. However, an important aspect in this context
is the level of expression regulation at which MSL-C acts. It
was proposed by Lucchesi (1998) that the MSL-C elevates
expression output by facilitating transcription elongation.
Genome-wide mappings have shown that the MSL-C and
MSL-C-dependent H4K16 acetylation is enriched within
gene bodies and biased to their 3′ ends (Alekseyenko et al.
2006; Gilfillan et al. 2006; Alekseyenko et al. 2008;K i n de t
al. 2008; Prestel et al. 2010b). These observations support
216 Chromosoma (2011) 120:213–225the view that MSL-C's main level of action is at transcription
elongation, which recently also gained experimental support
(Larschan et al. 2011). It should be noted that in principle,
the MSL-C may very well act at more than one level.
Although the MSL-C can explain a large extent of the
observed dosage compensation in Drosophila, and its main
level of action is likely to be in transcription elongation, we
still need to consider the likelihood that evolutionary
pressures have also acted at other levels of expression
regulation. We may, for example, consider male X
chromosome-specific processes acting on splicing, mRNA
release, and post-processing even if no specific evidence for
these possibilities have been presented as yet. Furthermore,
eukaryotic genomes are spatially organized and sub-nuclear
positioning may have important functions for accessibility
to transcription machineries and positioning in relation to
nuclear pores, the primary channels in the nuclear envelope
through which hnRNP molecules (for instance) pass. It has
been shown that certain NUP proteins, e.g., NUP98, bind
active genes (Capelson et al. 2010; Kalverda et al. 2010). If
the binding of NUPs is important for expression output and
their binding is sequence-dependent, this would also be a
level subject to evolutionary pressure. Although current
data are conflicting (see Grimaud and Becker 2009), a
biochemical association between NUP proteins and the
MSL-C has been suggested, and the nucleoporins Nup153
and Megator have proposed roles in dosage compensation
(Mendjan et al. 2006; Vaquerizas et al. 2010).
In principle, evolution of dosage compensation could
also act at the level of mRNA stability and decay. Although
this possibility has not been investigated in Drosophila as
yet, in mammals, it has been suggested that autosomal
genes are more likely to be subject to nonsense-mediated
mRNA decay (NMD) than X chromosomal genes. This is
suggested to have a role in the increased X/A expression
ratio observed in mammals (Yin et al. 2009). Finally,
equalization of expression output from the single male X
chromosome to that of the two X chromosomes in females
may also involve mechanisms that influence their transla-
tion efficiency and the activities of the encoded proteins.
Clearly, most of the observed dosage compensation can be
explained by the binding of MSL-C to the gene bodies of X
chromosome genes in males and the associated acetylation of
H4K16, which most likely facilitates elongation. Nevertheless,
as aneuploidies emerge, e.g., via proto-Y chromosome
degeneration, evolutionary pressure will act at many levels.
Importantly, MSL-C targets gene bodies and new blocks of
genes introduced to the X chromosome are relatively quickly
a d a p t e db yM S L - Ct a r g e t i n g( M a r i ne ta l .1996). We speculate
that MSL-C targeting may be considered as a secondary
adaption to the monosomic state. In contrast, as aneuploidies
emerge as a consequence of Y chromosome degeneration,
adaptation to the dose changes seems likely to be based more
on the regulation of individual genes. There may therefore be
two major stages in the evolution of dosage compensation
mechanisms. The first may be a primary adaptation, in which
selection acts at all levels listed above and solves the
problems associated with the emerging monosomic condition
at a gene-by-gene level. Different genes will have very
different requirements for compensation, thus the selection
pressure for their compensation will vary. In the next stage, a
uniform system may evolve, e.g., the MSL-C that compen-
sates for the changed doses of these emerging set of genes. A
likely scenario is that the MSL-C originated from a general
buffering system that subsequently evolved X chromosome
specificity. This may also explain the notion that upon the
addition of (for instance) a “new” X chromosomal arm, MSL-
C is recruited, but only when the homolog has degenerated
(Bone and Kuroda 1996; Marin et al. 1996). The involvement
of more than one system in dosage compensation is also
evident from the fact that the MSL-C only supports a 1.35-
fold rather than the full, required twofold. Interestingly,
combination of this “MSL-C-dependent” effect with the 1.4-
fold increase that seems to be general for all aneuploid regions
provides very close to the required twofold effect (Stenberg et
al. 2009; Prestel et al. 2010a; Zhang et al. 2010). The best
evidence for a link between general buffering and the
evolution of chromosome-wide gene regulation comes from
the studies of POF and the fourth chromosome.
Autosome-specific gene regulation
For a long time, chromosome-specific targeting was only
recognized for sex chromosomes and, accordingly,
chromosome-specific gene regulation was considered only
to function in dosage compensation. However, in D.
melanogaster, a second chromosome-wide targeting system
was described following the discovery of the protein
Painting of fourth (POF) (Larsson et al. 2001). POF
specifically targets, or “paints”, the fourth chromosome in
D. melanogaster, both male and female. Since the fourth
chromosome is an autosome, the discovery of POF serves
as a starting point to extend the exploration of
chromosome-wide regulatory functions to autosomes.
For comparing chromosomes between different Drosoph-
ila species and to consider the evolution of chromosome-
wide gene regulation mechanisms, it is convenient to
introduce Muller's naming of chromosomes. In Muller's
scheme, the chromosome arms are denoted elements A, B,
C, D, E, and F (Muller 1940). By definition, the X
chromosome of D. melanogaster is named element A,
chromosome arms 2L, 2R, 3L, and 3R are named element
B, C, D, E, respectively, and the fourth chromosome in D.
melanogaster is named element F. The major chromosome
arms in D. melanogaster, i.e., elements A–E, are of similar
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thus also sometimes designated the dot chromosome. The
presence of the F element as a unique small dot chromosome
is surprisingly well conserved within the genus Drosophila
(Ashburner et al. 2005). In a few described species, the F
element is fused to one of the major chromosome arm. In
Drosophila willistoni, the F element is fused to element E
(Papaceit and Juan 1998), and in Drosophila busckii and
Scaptodrosophila lebanonensis, the F element is fused to
element A and thus is part of the X chromosome in these two
species (Krivshenko 1955; Papaceit and Juan 1998). This
may actually represent the ancestral state, i.e., the F element
may originally have been part of the X chromosome (Fig. 3).
Evolution of the fourth chromosome
In most Drosophila species examined to date, the male X
chromosome is targeted by the MSL-C (Bone and Kuroda
1996; Marin et al. 1996) and the F element is targeted by
POF in both males and females (Larsson et al. 2004).
These two systems represent the two known chromosome-
specific targeting and gene regulatory systems in Dro-
sophila. The POF protein, similarly to the MSL-C,
decorates an entire chromosome by binding to interbands
(Fig. 2). There is evidence suggesting a relationship
between the X chromosome and the F element. The most
striking indication of such a relationship is probably that
in D. busckii, the F element is located at the base of the X
and the Y chromosomes, and there is no free F element
(dot chromosome) in this species. Instead, the X chromo-
some consists of the F element and the A element
separated by the nucleolus organizer (NO). In D. busckii,
a euchromatic-banded region in polytene chromosomes is
also present on the Y chromosome, suggested to be an F
element complement (Krivshenko 1952; Krivshenko
1955; Krivshenko 1959). Further support for the sug-
gested relationship between the F element and the X
chromosomes is provided by the minor role in sex
determination that has been described for the fourth
chromosome. Sexual fate in Drosophila is predicted by
the ratio of X chromosomes to autosomes, or more
specifically, the number of X chromosomes relative to
the number of precellular nuclear divisions (Cline and
Meyer 1996; Marin and Baker 1998;E r i c k s o na n d
Quintero 2007). In D. melanogaster, increased dosage of
the fourth chromosome will, in contrast to increased
dosage of the other autosomes, shift 2X:3A intersex
individuals towards female development, while decreased
dosage will shift intersex individuals towards male
development (Bridges 1925; Fung and Gowen 1960).
Hence, in terms of sex determination, the fourth chromo-
some behaves more like an X chromosome than an
autosome. In flies with three copies of the fourth
chromosome, an increased frequency of X chromosome
non-disjunction has been observed, suggesting that the
fourth chromosome has an intrinsic propensity to pair with
the X in meiosis (Sandler and Novitski 1956). Finally,
flies with only one copy of the fourth chromosome, i.e.,
haplo-4 flies, are viable and fertile. This is in marked
contrast to the effects of haploidy of the autosomes, but










Fig. 3 Phylogenetic relationships of studied species with simplified
karyotypes of males and females. The X chromosome is indicated as a
rectangle and the F element as an ellipse. MSL-C targets are indicated
in green and POF targets in red (Bone and Kuroda 1996; Marin et al.
1996; Larsson et al. 2001; Larsson et al. 2004). In D. willistoni, the F
element is fused to an autosome (gray rectangle). The conservation of
POF binding to the F element in species such as D. melanogaster, D.
pseudoobscura, and D. virilis, strongly indicates that this autosome-
specific regulatory system has an important function. The integration
of the F element in the X chromosome of D. busckii suggests that it
originated as part of the X chromosome and that POF was part of an
ancient dosage compensation system. The interrupted green on the D.
busckii male X chromosome indicates that this chromosome is
enriched in H4K16ac, but MSL-C has not been detected on it. In D.
ananassae and D. malerkotliana, both POF and MSL-C are present on
the male X chromosome (red/green), but only POF on the F element
in both sexes
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cient even if they uncover a region that in size and gene
number is comparable to the euchromatic part of chromo-
some 4. In summary, we can conclude that several lines of
evidence support a relationship between the F element and
the X chromosome, and although the most parsimonious
explanation is that the F element originated from the X
chromosome, this still remains elusive.
POF binding in different Drosophila species
As well as the binding of the MSL-C, the binding
properties of POF have been studied in an evolutionary
context, and the findings are summarized in Fig. 3. Initially,
POF was found to bind specifically to the fourth chromo-
some in D. melanogaster, and thus identified as an
autosome-specific targeting protein (Larsson et al. 2001).
This autosome-specific binding is conserved in evolution,
as demonstrated by the F element specificity (also detected,
for instance, in Drosophila pseudoobscura and Drosophila
virilis). The conservation of the autosome-specific proper-
ties of POF indicates that it confers selective advantage, and
thus that this autosome-specific targeting is functional. In
D. busckii, in which the F element is part of the X
chromosome, but also in Drosophila ananassae and
Drosophila malerkotliana where the F element is a separate
chromosome, POF shows male-specific targeting of the X
chromosome. In these three species, POF also colocalizes
with H4K16ac, which is indicative of a relationship to X
chromosome dosage compensation (Larsson et al. 2004). In
D. busckii, none of the MSL proteins have so far been
detected on the male X chromosome, but enrichment of
H4K16ac on the male X chromosome suggests that a
similar mechanism is involved (Marin et al. 1996; Larsson
et al. 2004). In D. ananassae, POF colocalizes perfectly
with the MSL-C on the male X chromosome and decorates
the F element both in males and females. Notably, the only
examined species in the genus Drosophila in which POF
has not been detected is D. willistoni. Here, the F element is
part of one of the major autosome arms as it is fused to
element E. It is not known how long ago this F+E fusion
occurred, but the F element is still retained as a unique
block in D. willistoni. Taken together, these findings show
that the binding of POF to the autosomic F element is
conserved, and thus represents an autosome-specific target-
ing mechanism with an autosome-specific function. Fur-
thermore, the binding to the male X together with the
colocalization of POF to the MSL-C and/or the male X
chromosome-enrichment of H4K16ac modification suggest
a connection to dosage-compensation functions. Thus, it
seems likely that POF originated as part of an ancient
dosage-compensation mechanism.
The fourth chromosome of D. melanogaster
The fourth chromosome in D. melanogaster is an odd
chromosome in many respects. It is late replicating
(Barigozzi et al. 1966; Zhimulev et al. 2003) and under
normal conditions, it exhibits very low levels of meiotic
recombination (Hochman 1976; Sandler and Szauter 1978;
Wang et al. 2002; Ashburner et al. 2005; Arguello et al.
2010). The banded region seen in polytene chromosomes
corresponding to cytogenetic bands 101E–102F appears as
a mosaic of unique sequences interspersed with repetitive
DNA with a high content of transposable elements (Miklos
et al. 1988; Pimpinelli et al. 1995; Locke et al. 1999a;
Locke et al. 1999b; Kaminker et al. 2002; Stenberg et al.
2005; Slawson et al. 2006; Leung et al. 2010). The fourth
chromosome is also enriched in histone modifications and
chromatin-associated proteins that are enriched in hetero-
chromatin. For example, the heterochromatin protein HP1
is enriched on the fourth chromosome, as are specific
histone modification markers of heterochromatin, e.g.,
methylated H3K9 (Eissenberg et al. 1992; Czermin et al.
2002; Schotta et al. 2002). In principle, the entire fourth
chromosome can be regarded as the “green-chromatin”
according to the definition by van Steensel and coworkers
(Filion et al. 2010). In line with these heterochromatic, and
thus gene-silencing properties, reporter genes inserted on
the fourth chromosome often show a partially silenced,
variegated expression (Wallrath and Elgin 1995; Wallrath et
al. 1996; Sun et al. 2000). The fourth chromosome consists
of a 3–4-Mb proximal part (Locke and McDermid 1993)
and a banded, sequenced part that is approximately 1.3 Mb
long. Interestingly, despite its heterochromatic properties,
the sequenced part of the chromosome includes 92 genes;
hence, it has similar gene density to the major chromosome
arms. Moreover, the average level of expression of genes
on this chromosome is comparable to, or even higher than,
that of genes on the other chromosomes (Haddrill et al.
2008) (Johansson, Stenberg and Larsson unpublished). The
sequence composition of the fourth chromosome is also
abnormal in comparison to the other chromosomes in D.
melanogaster. In fact, its structure with scattered repetitive
elements is reminiscent of the organization of mammalian
chromosomes. Thus, the genes located on the fourth
chromosome appear to be adapted to function in this
hostile, repressive environment.
Chromatin environment of the fourth chromosome
In line with its enrichment of repeated sequences, the fourth
chromosome is targeted by typical heterochromatin histone
modifications, e.g., methylated H3K9. At least three H3K9-
specific methyl transferases mediate the methylation of H3K9
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thoroughly studied of these transferases is Su(var)3–9, which
was initially found in genetic screens together with Su(var)
2–5 (encoding HP1) as suppressors of position-effect
variegation (Schotta et al. 2003). Methylated H3K9 stabilizes
the binding of HP1 to chromatin, and this modification is
generally mediated by Su(var)3–9. However, in Su(var)3–9
mutants, levels of pericentric H3K9me and pericentric HP1
are reduced, except on the fourth chromosome where levels
of H3K9me appear to be unaltered (Czermin et al. 2002;
Schotta et al. 2002; Ebert et al. 2004). This apparent
discrepancy has recently been explained by findings that
the Drosophila Setdb1 controls H3K9 methylation in the
fourth chromosome (Seum et al. 2007; Tzeng et al. 2007).
Hence, chromosome 4 is similar to pericentric heterochro-
matin in its methylated H3K9 enrichment, but this enrich-
ment is mediated by different proteins. These K9-methylated
H3 tails are targeted by the N-terminal chromo-domain of
HP1 (Bannister et al. 2001; Lachner et al. 2001;N a k a y a m a
et al. 2001; Jacobs and Khorasanizadeh 2002). The proposed
model for HP1-mediated chromatin condensation postulates
that HP1 forms a dimer through its C-terminal shadow
domains, and the two chromo-domains in the dimer link two
adjacent nucleosomes. The spreading is proposed to be
mediated by interaction between HP1 and the histone methyl
transferase Su(var)3–9 (or Setdb1), which methylates nearby
H3K9 and thus propagates spreading of the methylation and
HP1 interaction. Although HP1's interaction with chromatin
is mainly considered to act through methylated H3K9, it
should be stressed that HP1 has also been shown to interact
with high affinity to the H3 histone-fold on oligonucleoso-
mal arrays (Nielsen et al. 2001; Dialynas et al. 2006;B i l l u r
et al. 2010). This interaction may be represented by a small,
but stable, fraction of HP1 associated with chromatin.
Chromosome-specific regulation of the fourth
chromosome
Despite the repressive nature of the fourth chromosome, the
genes located on it are properly expressed, possibly partly
because of the activity of the chromosome 4-specific
protein POF. In contrast to HP1, which binds the fourth
chromosome as well as pericentric heterochromatin, POF is
highly specific for the banded part of the fourth chromo-
some. In this region, POF and HP1 colocalize close to
perfectly at the resolution afforded by polytene chromo-
some staining (Johansson et al. 2007a). The binding of POF
and HP1 is interdependent, hence POF binding to the fourth
is strongly reduced in HP1 mutants and HP1 binding is
reduced in Pof mutants (Johansson et al. 2007a). Although
POF binds to the banded, gene rich region of the fourth
chromosome, the results suggest that POF requires heter-
chromatic pressure for its targeting. This hypothesis has
been corroborated by studies showing that a translocated
fourth chromosome will not be targeted by POF unless the
proximal heterochromatic region is present, and conditions
favor heterochromatin formation (e.g., low temperature
and/or absence of a Y chromosome) (Johansson et al.
2007a).
Both POF and HP1 have been mapped on the fourth
chromosome to high resolution using the ChIP-chip
technique (Johansson et al. 2007b). At ChIP-chip resolu-
tion, POF and HP1 colocalization within the transcribed
region of chromosome 4 genes is close to perfect. The
enrichment levels of these two factors show a linear
correlation, and the HP1 and POF binding levels also
positively correlate with transcription levels (Johansson et
al. 2007b). In addition to the binding within genes, HP1
shows a distinct promoter-binding peak in almost all genes
on the fourth chromosome if they are expressed (Johansson
et al. 2007a). HP1 targets on the fourth chromosome can
thus be divided into two distinct sets: one within the
transcribed region and one in the promoters. POF, on the
other hand, is only seen within the transcribed gene region.
Reduction of HP1 levels causes increased expression of
chromosome 4 genes, whereas loss of Pof causes a decrease
in chromosome 4 expression (Johansson et al. 2007b). In D.
melanogaster, haplo-4 flies are viable and fertile. However,
the expression of non-ubiquitously expressed genes on the
fourth chromosome has been shown to be compensated by
POF in these flies, and the lack of this compensation causes
lethality (Stenberg et al. 2009). In contrast, there is very
little or no compensation for ubiquitously expressed genes.
The POF-mediated compensation of chromosome 4 genes
is more effective than the observed buffering of segmental
aneuploidies. However, these two systems show many
striking similarities, e.g., in the differences in their effects
on differentially expressed and ubiquitously expressed
genes (Stenberg et al. 2009). A balancing model has been
proposed suggesting that POF and HP1 stimulate and
repress, respectively, gene expression from the fourth
chromosome, thus together they provide a buffer that
prevents excessive transcription fluctuation. However, if
HP1 and POF are interdependent, why does their mutation
have opposite effects on transcription output? It is tempting
to speculate that the removal of POF causes a reduction in
HP1 levels, but that some HP1, for example in the promoter
peak, remains and the repressive function dominates. In the
opposite situation, when HP1 is reduced, some POF may
still be present, and the stimulating function may dominate.
An intriguing observation is that silenced transgenes on the
fourth chromosome are preferentially located in HP1-rich
regions, whereas non-silenced transgenes are preferentially
located in regions with low amounts of HP1 (Stenberg et al.
2009). On chromosome 4, high levels of HP1 are observed
220 Chromosoma (2011) 120:213–225in transcribed (and thus active) regions; so why are
transgenes silenced? Maybe the HP1 protein will spread
into these transgenes, but since these sequences do not have
a chromosome 4 origin, POF will not target them. If so, the
silencing properties of HP1 would dominate. This possibil-
ity has not been tested as yet.
The molecular mechanism of POF-mediated stimulation
of gene transcription remains elusive. However, since POF
has an RNA-binding domain, it is likely that POF is
recruited through nascent RNA from actively transcribing
chromosome 4 genes. Whether the stimulation of expres-
sion occurs through the promotion of transcription, more
efficient splicing, or enhanced export, remains to be
determined. The prevailing model for the repressive nature
of HP1 is that it targets methylated H3K9, forms a dimer,
and links two adjacent nucleosomes. However, it should be
stressed that HP1 is not solely linked to gene repression. It
is also known to be required for transcription of some genes
located within heterochromatic regions (Hearn et al. 1991;
Clegg et al. 1998;L ue ta l .2000), it has been shown to be
associated with active genes in euchromatic regions, and
gene expression analyses suggest that in some cases, HP1
stimulates transcription (Piacentini et al. 2003; Cryderman
et al. 2005). It was also recently shown that HP1 associates
with transcripts of hundreds of euchromatic Drosophila
genes and that HP1 positively regulates these genes
(Piacentini et al. 2009). A suggested model proposes that
HP1's main function is nucleic acid compaction, which can
act on both DNA and RNA. Compaction of DNA through
binding to methylated H3K9 will cause repression, while
compaction of RNA via interaction with hnRNP proteins
may stabilize the messenger and support gene expression
(Piacentini et al. 2009).
Why is the binding of POF and HP1 interdependent? So
far, no evidence of physical association between POF and
HP1 has been reported, but POF and Setdb1 have been
shown to interact in vitro (Tzeng et al. 2007). Thus, POF
may provide an adaptor system linking histone marks via
HP1 and Setdb1 to pre-mRNA, in similar fashion to
MRG15 and PTB (Luco et al. 2010; Luco et al. 2011).
POF in testes
POF is expressed at low levels in most, if not all cells, in
both males and females. However, it is expressed at very
high levels in testes. A number of appealing hypotheses
could explain this strong germline expression. First, the X
chromosome is also dosage-compensated in the male
germline, but no mechanism for this compensation has
been yet been characterized (Bachiller and Sánchez 1986;
Rastelli and Kuroda 1998; Gupta et al. 2006). The strong
relationship between POF and dosage compensation sug-
gests that POF may have an X chromosome dosage-
compensation function in the germline. However, expres-
sion microarray analysis has shown that the expression of
the X chromosome is not affected in Pof mutant testes
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Fig. 4 Putative origins of the X chromosome, the F element, and the
compensatory systems POF (red)a n dM S L - C( green). MDA indicates
the male determining allele. Upon degeneration of the proto-Y
chromosome, the corresponding regions of the proto-X chromosome
will require buffering of haploid regions, indicated by brown boxes.
Parts of these general buffering systems later evolved into dosage
compensation systems (POF and MSL-C). The interrupted green on D.
busckii male X chromosome indicates that this chromosome is enriched
in H4K16ac, but MSL-C has not been detected on it. The F element is
indicated by an ellipse
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ment of the fourth chromosome. In the male germline, the
genes on the Y chromosome should be expressed, and these
genes are also located in a heterochromatic environment.
However, expression analysis has shown that in the testes,
POF mainly influences expression of chromosome 4 genes,
and Pof mutants are not male sterile (Stenberg et al. 2009).
Third, the fourth chromosome lacks recombination, which
is also a hallmark of the Drosophila male germline. POF
may therefore act as a suppressor of recombination.
However, although this possibility has not been fully
excluded, Pof mutants lack recombination both of the
fourth chromosome and in the male germline. Thus, it
seems that stimulation of expression of genes located on
chromosome 4 is the main function of POF in both
germline and somatic cells.
Origin of MSL- and POF-mediated dosage
compensation mechanisms
An obvious question to address is why there is a
chromosome-specific gene regulatory mechanism for the
fourth chromosome. Possible clues are that POF is required
for haplo-4 survival, and somatic elimination of the fourth
chromosome is relatively frequent in D. melanogaster
(Mohr 1932; Ashburner et al. 2005), although the fourth
chromosome is normally present in diploid form in both
males and females. Thus, POF may be important for
sufficient expression of chromosome 4 genes in haplo-4
cells. It seems unlikely that the sole selective advantage of
the system is aiding the survival of haplo-4 cells or
individuals. However, there is a strong relationship between
the X and the fourth chromosomes, and POF may indeed
originate from a buffering/dosage compensating system.
Astheproto-Ygraduallydegenerated,initialcompensation
of the monosomic X regions was probably provided by
general buffering mechanisms that evolved due to the need to
cope with general dosage differences (Fig. 4). These
mechanisms would have acted at different levels of
expression regulation with varying levels of compensation
precision. During the course of Y degeneration, some of
these systems would have had to become specific for the X
chromosome to avoid the genomic instability associated with
over-efficient general buffering. The resulting X specificity
would be advantageous to males but would be accompanied
with risks of overexpression in females. Participants in the X
chromosome-specific systems that evolved include MSL,
and most likely POF, since POF is observed on the male X
chromosome in some species (Fig. 3). The F element, as part
of the X chromosome, is most likely the ancestral state, and
after the split of the ancestral D. busckii (Fig. 3), the F
element detached from the X.
In D. busckii, in which the F element has been retained as
part of the X chromosome, both POF and MSL compensate
for the difference between sexes in copy number of genes on
the X chromosome. In contrast, in other species (e.g., D.
melanogaster, in which the F element is a unique autosome),
the two systems appear to have diverged and now target
different chromosomes and meet distinct compensatory
needs. However, an intrinsic propensity of the MSL-C to
target the F element is still observable in roX1 roX2 mutants
(Meller and Rattner 2002; Deng and Meller 2006). The
retention of POF on the F element allows correct expression,
despite the heterochromatic nature of this chromosome. This
may in turn have caused a functional constraint of the genes
located on the fourth chromosome, which may explain the
conservation of the F element as a unique dot chromosome
in many Drosophila species.
Shaping the genome
Compensatory and buffering systems provide molecular
mechanisms that can counter problems associated with
changes in gene copy number that emerge during the course
of evolution and allow potentially beneficial variations in
genome structure. Clearly, CNV is an important evolution-
ary driving force, and a delicate balance is needed between
compensating for variations in gene doses (thus permitting
variability) and selection against excessively destabilizing
variation. Equally clearly, general buffering systems can be
modified in ways that meet compensatory requirements and
may provide templates for the evolution of a wide range of
specific regulatory mechanisms. Considering the abundance
of functional constraints on gene organization, clustering
and order, and the conservation of many syntenic regions, it
seems likely that several autosome-specific targeting sys-
tems in other organisms remain to be discovered.
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